Evaluating MMP expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer
US8183008B2 · kind B2 · utility
3Cited by
2References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 2008 |
| Grant date | May 22, 2012 |
| Priority date | — |
| Expiry date | Apr 11, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57484
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Provided are compositions, methods and kits for quantifying the expression and/or activity of MMP-14 and other biomarkers of cancer, which may be used diagnostically and prognostically, e.g., in patient stratification and evaluation of appropriate therapeutic regimens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.